These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 9875414)

  • 1. 3-Hydroxyphthaloyl beta-lactoglobulin. IV Antiviral activity in the mouse model of genital herpesvirus infection.
    Kokuba H; Aurelian L; Neurath AR
    Antivir Chem Chemother; 1998 Jul; 9(4):353-7. PubMed ID: 9875414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-Hydroxyphthaloyl beta-lactoglobulin. III. Antiviral activity against herpesviruses.
    Neurath AR; Strick N; Li YY
    Antivir Chem Chemother; 1998 Mar; 9(2):177-84. PubMed ID: 9875389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellulose acetate phthalate (CAP): an 'inactive' pharmaceutical excipient with antiviral activity in the mouse model of genital herpesvirus infection.
    Gyotoku T; Aurelian L; Neurath AR
    Antivir Chem Chemother; 1999 Nov; 10(6):327-32. PubMed ID: 10628808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2.
    Parr MB; Kepple L; McDermott MR; Drew MD; Bozzola JJ; Parr EL
    Lab Invest; 1994 Mar; 70(3):369-80. PubMed ID: 8145530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral and immunological effects of tenofovir microbicide in vaginal herpes simplex virus 2 infection.
    Vibholm L; Reinert LS; Søgaard OS; Paludan SR; Østergaard L; Tolstrup M; Melchjorsen J
    AIDS Res Hum Retroviruses; 2012 Nov; 28(11):1404-11. PubMed ID: 22867119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effect of meliacine, an antiviral derived from Melia azedarach L., in mice genital herpetic infection.
    Petrera E; Coto CE
    Phytother Res; 2009 Dec; 23(12):1771-7. PubMed ID: 19441066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of resveratrol on herpes simplex virus vaginal infection in the mouse.
    Docherty JJ; Fu MM; Hah JM; Sweet TJ; Faith SA; Booth T
    Antiviral Res; 2005 Sep; 67(3):155-62. PubMed ID: 16125258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observations on recovery from and recurrence of HSV-2 infections in adult mice that were rescued from lethal vaginal infection by antiviral therapy.
    Parr EL; Holliday EM; Collard MW; Parr MB
    Arch Virol; 2005 Sep; 150(9):1885-902. PubMed ID: 15824886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update on short-course episodic and prevention therapies for herpes genitalis.
    Corey L; Bodsworth N; Mindel A; Patel R; Schacker T; Stanberry L
    Herpes; 2007 Jun; 14 Suppl 1():5A-11A. PubMed ID: 17877886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An immunomodulating dipeptide, SCV-07, is a potential therapeutic for recurrent genital herpes simplex virus type 2 (HSV-2).
    Rose WA; Tuthill C; Pyles RB
    Int J Antimicrob Agents; 2008 Sep; 32(3):262-6. PubMed ID: 18619817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infection.
    Gill N; Rosenthal KL; Ashkar AA
    J Virol; 2005 Apr; 79(7):4470-8. PubMed ID: 15767447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of a natural carrageenan on genital herpes simplex virus infection in mice.
    Carlucci MJ; Scolaro LA; Noseda MD; Cerezo AS; Damonte EB
    Antiviral Res; 2004 Nov; 64(2):137-41. PubMed ID: 15498610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of herpes simplex virus type 2 infection in HIV type 1-infected persons.
    Strick LB; Wald A; Celum C
    Clin Infect Dis; 2006 Aug; 43(3):347-56. PubMed ID: 16804851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estradiol regulates susceptibility following primary exposure to genital herpes simplex virus type 2, while progesterone induces inflammation.
    Gillgrass AE; Fernandez SA; Rosenthal KL; Kaushic C
    J Virol; 2005 Mar; 79(5):3107-16. PubMed ID: 15709030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical properties, mode of action, and in vivo anti-herpes activities of a lignin-carbohydrate complex from Prunella vulgaris.
    Zhang Y; But PP; Ooi VE; Xu HX; Delaney GD; Lee SH; Lee SF
    Antiviral Res; 2007 Sep; 75(3):242-9. PubMed ID: 17475343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of polyanionic compounds on intracutaneous and intravaginal herpesvirus infection in mice: impact on the search for vaginal microbicides with anti-HIV activity.
    Neyts J; De Clercq E
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):8-12. PubMed ID: 7648289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical resiquimod 0.01% gel decreases herpes simplex virus type 2 genital shedding: a randomized, controlled trial.
    Mark KE; Corey L; Meng TC; Magaret AS; Huang ML; Selke S; Slade HB; Tyring SK; Warren T; Sacks SL; Leone P; Bergland VA; Wald A
    J Infect Dis; 2007 May; 195(9):1324-31. PubMed ID: 17397003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
    Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA
    Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactoferricin but not lactoferrin inhibit herpes simplex virus type 2 infection in mice.
    Shestakov A; Jenssen H; Nordström I; Eriksson K
    Antiviral Res; 2012 Mar; 93(3):340-5. PubMed ID: 22269645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection.
    Da Costa XJ; Morrison LA; Knipe DM
    Virology; 2001 Sep; 288(2):256-63. PubMed ID: 11601897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.